{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Fate Therapeutics, Inc., San Diego, CA, USA",
    "1Fate Therapeutics, San Diego, CA, USA",
    "1Fate Therapeutics, Inc., San Diego, CA, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 14,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Hui-Yi Chu"
    },
    {
      "affs": [
        1
      ],
      "name": "Bahram Valamehr"
    },
    {
      "affs": [
        2
      ],
      "name": "Soheila Shirinbak"
    },
    {
      "affs": [
        1
      ],
      "name": "Eigen Peralta"
    },
    {
      "affs": [
        1
      ],
      "name": "Thomas Dailey"
    },
    {
      "affs": [
        2
      ],
      "name": "Miguel Meza"
    },
    {
      "affs": [
        1
      ],
      "name": "Masanao Tsuda"
    },
    {
      "affs": [
        1
      ],
      "name": "Bi-Huei Yang"
    },
    {
      "affs": [
        0
      ],
      "name": "Olena A Kolesnichenko"
    },
    {
      "affs": [
        0
      ],
      "name": "Sean P Sherman"
    },
    {
      "affs": [
        0
      ],
      "name": "Alma Gutierrez"
    },
    {
      "affs": [
        0
      ],
      "name": "Alex J Garcia"
    },
    {
      "affs": [
        0
      ],
      "name": "Tom T Lee"
    },
    {
      "affs": [
        0
      ],
      "name": "Martin P Hosking"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/4wzbagp79yqtg.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0203",
  "fulltext_url": null,
  "id": "4wzbagp79yqtg",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0203",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|CAR-T cell therapy research"
    ]
  ],
  "openalex": "W7225169647",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A231.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-04",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/4wzbagp79yqtg.ris",
  "sources": [
    {
      "first_seen": "2026-11-05T14:21:01Z",
      "native_id": "1faf00499ebc43d69c015d3208867eb3",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0203"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|CAR-T cell therapy research",
      "subfield": "oncology"
    }
  ],
  "title": "203 Dual targeting of uPAR and MICA/B with multiplexed-engineered CAR T cells offers a unique therapeutic strategy in fibrotic disease",
  "title_text": "203 Dual targeting of uPAR and MICA/B with multiplexed-engineered CAR T cells offers a unique therapeutic strategy in fibrotic disease",
  "type": "peer-reviewed",
  "updated_at": "2026-11-06T14:20:30Z",
  "url": "https://research.draconitic.com/paper/4wzbagp79yqtg",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}